Free tool · Biotech runway simulator
Will your cash last until your next milestone?
Enter your cash, monthly burn, next R&D milestone and expected financing. See your runway, the cash left at the milestone and the funding you would still need, in three scenarios.
Run your numbers
Calculated in your browser. Nothing you enter is sent to Helix or any third party.
Your biotech
Amounts in EUR millions. Change any value; results update as you type.
Next value-creating milestone
Spread evenly until the milestone; exclude costs already in burn.
Financing and uncertainty
Month 0 is today. The model assumes the round closes on time.
Month 0, as YYYY-MM. Set from your browser's clock; used only to print dates.
The file is created in your browser. Nothing is saved: reloading resets the inputs, so export to keep them.
Funded to Preclinical proof of concept (month 12): in the base case, cash never goes below zero before the milestone.
Results
Funded to milestoneFunded to Preclinical proof of concept (month 12): in the base case, cash never goes below zero before the milestone.
- Cash runway
- 20.3 months
- Until the balance goes below zero. Without the expected financing: 13.2 months.
- Cash at milestone
- €2.34M
- at month 12, including expected financing.
- Additional funding needed
- €0.00M
- The deepest cash deficit before the milestone, beyond the expected financing.
- Optimistic
- Base case (thick)
- Downside (dashed)
Show the monthly figures
| Month | Date | Base | Optimistic | Downside |
|---|---|---|---|---|
| 0 | — | €4.50M | €4.50M | €4.50M |
| 1 | — | €4.15M | €4.18M | €4.12M |
| 2 | — | €3.81M | €3.86M | €3.74M |
| 3 | — | €3.46M | €3.55M | €3.36M |
| 4 | — | €3.11M | €3.23M | €2.98M |
| 5 | — | €2.77M | €2.91M | €2.60M |
| 6 | — | €2.42M | €2.59M | €2.22M |
| 7 | — | €2.07M | €2.27M | €1.84M |
| 8 | — | €1.73M | €1.96M | €1.46M |
| 9 | — | €3.38M | €3.64M | €3.08M |
| 10 | — | €3.03M | €3.32M | €2.70M |
| 11 | — | €2.69M | €3.08M | €2.32M |
| 12 | — | €2.34M | €2.84M | €1.93M |
| 13 | — | €2.06M | €2.61M | €1.55M |
| 14 | — | €1.78M | €2.37M | €1.17M |
| 15 | — | €1.50M | €2.13M | €0.79M |
| 16 | — | €1.22M | €1.89M | €0.41M |
| 17 | — | €0.94M | €1.65M | €0.03M |
| 18 | — | €0.66M | €1.42M | −€0.35M |
| 19 | — | €0.38M | €1.18M | −€0.68M |
| 20 | — | €0.10M | €0.94M | −€1.02M |
| 21 | — | −€0.18M | €0.70M | −€1.36M |
| 22 | — | −€0.46M | €0.46M | −€1.69M |
| 23 | — | −€0.74M | €0.23M | −€2.03M |
| 24 | — | −€1.02M | −€0.01M | −€2.36M |
| 25 | — | −€1.30M | −€0.25M | −€2.70M |
| 26 | — | −€1.58M | −€0.49M | −€3.04M |
| 27 | — | −€1.86M | −€0.73M | −€3.37M |
| 28 | — | −€2.14M | −€0.96M | −€3.71M |
| 29 | — | −€2.42M | −€1.20M | −€4.04M |
| 30 | — | −€2.70M | −€1.44M | −€4.38M |
| 31 | — | −€2.98M | −€1.68M | −€4.72M |
| 32 | — | −€3.26M | −€1.92M | −€5.05M |
| 33 | — | −€3.54M | −€2.15M | −€5.39M |
| 34 | — | −€3.82M | −€2.39M | −€5.72M |
| 35 | — | −€4.10M | −€2.63M | −€6.06M |
| 36 | — | −€4.38M | −€2.87M | −€6.40M |
Three possible futures
Optimistic
23.9 months
cash runway
- Milestone:
- month 10
- Cash at milestone:
- €3.32M
- Funding needed:
- €0.00M
Reaches the milestone
Base case
20.3 months
cash runway
- Milestone:
- month 12
- Cash at milestone:
- €2.34M
- Funding needed:
- €0.00M
Reaches the milestone
Downside
17.0 months
cash runway
- Milestone:
- month 18
- Cash at milestone:
- −€0.35M
- Funding needed:
- €0.35M
Misses the milestone
- Optimistic: burn 15% lower, milestone 2 months earlier (month 1 at the earliest). Downside: burn 20% higher, milestone delayed by the chosen delay.
- Milestone-specific costs stay the same in total and are spread over each scenario's own timeline: a delay raises cost only through the monthly burn.
- The financing date is the same in every scenario. These factors are illustrative assumptions, not benchmarks.
How it is calculated
The model works month by month, from today (month 0) to at least month 36, and further when the downside milestone falls later (up to month 48). Each month, the balance moves by the expected financing if it arrives that month, minus the monthly net burn, minus an equal share of the milestone-specific cost until the milestone. Financing that arrives in a month pays that month's spending.
Cash runway is the time until the balance first goes below zero, interpolated within the month and shown truncated to one decimal, never rounded up. A balance of exactly zero is not a shortfall.
Additional funding needed is the deepest cumulative deficit between today and the milestone, beyond the financing you expect. If the round closes after cash runs out, the gap before it still counts: the company would have had no cash in between.
Scenarios. Optimistic: burn 15% lower and the milestone 2 months earlier. Downside: burn 20% higher and the milestone delayed by the delay you choose. The milestone cost is the same total in every scenario, spread over that scenario's own timeline, and the financing date does not move. These factors are illustrative assumptions, not benchmarks.
Below zero, the chart shows an unfunded deficit: the amount that would have to be raised, not cash that can be spent.
What the model leaves out
- One financing event only: no tranches, grants paid in instalments, debt or R&D tax credit.
- No inflation, currency effects or taxes; burn is constant within each scenario.
- Monthly resolution: a payment due mid-month is treated as spread over the month.
- A financing that closes late is not modelled; test it by moving the arrival month.
Built by the Atlas team
Cash is one number. The evidence behind your milestone is the rest.
Atlas keeps the trials, papers, patents and funding around your program in one place, each with its source, so the next milestone decision rests on what is known.
An illustrative cash-flow model, not financial, investment or regulatory advice. The results depend entirely on the figures you enter and on the stated assumptions.
